WCLC: IASLC Issues Statement on Tobacco Control and Smoking Cessation
The International Association for the Study of Lung Cancer (IASLC) issued a new statement on Tobacco Control and Smoking Cessation on September 7 at the 16th World Conference on Lung Cancer (WCLC) in Denver, Colorado. The statement calls for higher taxes on tobacco products; comprehensive advertising and promotion bans of all tobacco products; and product regulation, including pack warnings.
“Tax policies that increased the cost of cigarettes have played a prominent role in the reduction of cigarette smoking,” said Kenneth Michael Cummings, PhD, MPH, Professor at the Hollings Cancer Center of the Medical University of South Carolina and Co-Chair of IASLC’s Tobacco Control and Smoking Cessation Committee.
Dr. Cummings and the Committee highlighted a recent estimate that showed that doubling the inflation-adjusted price of cigarettes could result in a 33% reduction in smoking prevalence. Many low- and middle-income countries can accomplish this by tripling the specific excise tax on tobacco. A low-specific excise tax on tobacco is the main reason that, even after adjustment for purchasing power, cigarettes are about 70% cheaper in many low-income countries compared with high-income countries.
Main Points of Change
IASLC urges its members and others around the world to:
- Join together to forcefully implement the World Health Organization’s Framework Convention on Tobacco Control, which has among its key provisions increasing cigarette prices via taxation (to at least 70% of the retail price); prohibiting the sale of cigarettes to minors (less than 21 years of age); enacting and enforcing comprehensive cigarette marketing policies; eliminating tobacco use in public locations; mandating graphic warning labels on cigarette containers; implementing public education campaigns to discourage the use of cigarettes; and providing tobacco cessation support.
- Adopt legal reforms that allow people who smoke and their families to use the judicial system to hold tobacco manufacturers civilly and criminally accountable for selling products that are deadly when used as intended.
- Support programs to prevent smoking initiation habits in children and in youth, and recognize that any attempts to induce nicotine consumption in this population should be avoided.
- Implement tobacco cessation programs in their clinics, hospitals, and cancer centers to assist their patients in achieving the best possible outcomes from their cancer treatment.
- Adopt policy measures that recognize the probable differences in the lung cancer risk of alternative nicotine delivery products. Adopting policies that favor less dangerous (noncombustible) forms of nicotine delivery over cigarettes would provide a powerful incentive for people who smoke to move away from cigarettes, which in turn would have a profound impact on global lung cancer rates in the coming decades.
To view the complete tobacco declaration, click here.
The content in this post has not been reviewed by the American Society of Clinical Oncology, Inc. (ASCO®) and does not necessarily reflect the ideas and opinions of ASCO®.
